<DOC>
	<DOCNO>NCT02061098</DOCNO>
	<brief_summary>The investigator objective carry placebo-controlled , dose-response , randomized clinical trial ass effect polyphenols derive metabolite cardiovascular disease risk overweight adult subject upon consumption pomegranate extract . The investigator hypothesis chronic consumption ellagitannin-rich source pomegranate extract could decrease serum oxidized-LDL well inflammatory marker . The correlation effect exert subject ' microbiota ( capacity produce ellagitannin-derived metabolite urolithins ) indicate possible role urolithins effect .</brief_summary>
	<brief_title>Effect Pomegranate Extract Cardiovascular Risk Markers Overweight Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<criteria>Aged 4065 year Body mass index ( BMI ) &gt; 27 kg/m2 Healthy status ( illness previous 3months ) . Smoking . Pregnancy/lactation . Severe medical illness/chronic disease/ gastrointestinal pathology ( ulcer , irritable bowel syndrome , ulcerative colitis , Crohn disease etc. ) . Previous gastrointestinal surgery Recent use antibiotic ( within 1month prior study ) Suspected hypersensitivity pomegranate component Consumption nutraceuticals , botanical extract vitamin supplement take medication . Regular consumption ellagitannincontaining foodstuff ( walnut , pomegranate , strawberry , raspberry , oakaged red wine ) ( fill foodfrequency questionnaire ) . Intake ellagitanninscontaining foodstuff week pharmacokinetic intervention .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Pomegranate</keyword>
	<keyword>Cardiovascular</keyword>
	<keyword>Urolithins</keyword>
	<keyword>Microbiota</keyword>
	<keyword>Polyphenols</keyword>
	<keyword>Nutraceutical</keyword>
	<keyword>Dietary supplement</keyword>
</DOC>